Matches in Wikidata for { <http://www.wikidata.org/entity/Q91134589> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q91134589 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91134589 description "scientific article published on 17 February 2019" @default.
- Q91134589 description "wetenschappelijk artikel" @default.
- Q91134589 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91134589 description "գիտական հոդված հրատարակված 2019 թվականի փետրվարի 17-ին" @default.
- Q91134589 name "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 name "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 type Item @default.
- Q91134589 label "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 label "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 prefLabel "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 prefLabel "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 P1433 Q91134589-2CAE800C-0364-4944-91A0-229646FCAA4B @default.
- Q91134589 P1476 Q91134589-A4735F9F-C52B-428D-A510-5795BEBCFD53 @default.
- Q91134589 P2093 Q91134589-1DBF1940-092A-4057-B720-E6773DE36401 @default.
- Q91134589 P2093 Q91134589-84DDB85C-6448-4E4D-9A64-5379C6C60B55 @default.
- Q91134589 P304 Q91134589-6E44EA86-811D-4EAB-A6A9-59733CD5AF25 @default.
- Q91134589 P31 Q91134589-4FA38BEB-30F6-4BF7-9967-6066943ABF10 @default.
- Q91134589 P356 Q91134589-BE1E5BFF-B7DE-4479-8BCF-9A015691C242 @default.
- Q91134589 P433 Q91134589-1F36BE9C-351F-4B09-ADCA-8B89CEECA1C3 @default.
- Q91134589 P478 Q91134589-7620A816-1F14-4BBE-B1F3-C149454622BA @default.
- Q91134589 P50 Q91134589-1571CD54-1AB4-441F-8F23-DBD99351FF52 @default.
- Q91134589 P50 Q91134589-F650B5E6-BB56-4A82-9E71-30CDB9B5F8EB @default.
- Q91134589 P577 Q91134589-F36F24A8-13AC-4D4A-A709-E8C1BA32EB17 @default.
- Q91134589 P698 Q91134589-E921B71D-FFEC-4475-BDD6-C48A2444AA35 @default.
- Q91134589 P356 JLCR.3707 @default.
- Q91134589 P698 30663095 @default.
- Q91134589 P1433 Q3186923 @default.
- Q91134589 P1476 "Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators" @default.
- Q91134589 P2093 "Ashutosh Dash" @default.
- Q91134589 P2093 "Naresh Gamre" @default.
- Q91134589 P304 "158-165" @default.
- Q91134589 P31 Q13442814 @default.
- Q91134589 P356 "10.1002/JLCR.3707" @default.
- Q91134589 P433 "4" @default.
- Q91134589 P478 "62" @default.
- Q91134589 P50 Q91134585 @default.
- Q91134589 P50 Q91134587 @default.
- Q91134589 P577 "2019-02-17T00:00:00Z" @default.
- Q91134589 P698 "30663095" @default.